Rhythm Biotherapeutics Inc.
$30,000.00 CAD
≈ 5 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- June 1, 2025 – March 31, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q2-1032998
Published purpose
This project investigates the use of cardiac-derived biological particles as a novel, non-invasive therapy for atrial inflammation in a rat model that mimics postoperative atrial fibrillation. The particles will be administered and assessed for targeted uptake by heart tissue. The ultimate aim is to demonstrate that this approach can prevent atrial fibrosis and halt the progression of atrial fibrillation.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions